Pharma Mar SA (PHM) Price & Analysis

Compare

15 Followers

PHM Stock Chart & Stats

Day’s Range― - ―

52-Week Range€31.82 - €105.80

Previous CloseN/A

Volume4.24K

Average Volume (3M)69.70K

Market Cap

$1.47B

Enterprise Value€858.32M

Total Cash (Recent Filing)$140.85M

Total Debt (Recent Filing)€51.94M

Price to Earnings (P/E)72.2

Beta1.13

Next Earnings

Jul 24, 2025

EPS Estimate

0.03

Next Dividend Ex-Date

Jun 25, 2025

Dividend Yield0.78%

Share Statistics

EPS (TTM)-0.23

Shares Outstanding18,222,227

10 Day Avg. Volume114,077

30 Day Avg. Volume69,699

Financial Highlights & Ratios

PEG Ratio-0.50

Price to Book (P/B)5.21

Price to Sales (P/S)0.00

P/FCF Ratio39.38

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$109.00

Price Target Upside34.57% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Pharma Mar SA News

PremiumCompany Announcements

Pharma Mar SA Announces Dividend Payment for 2025

21h ago

PremiumCompany Announcements

Pharma Mar S.A. Shareholders Approve Board Proposals

21h ago

PremiumCompany Announcements

Pharma Mar’s Strategic Shareholder Meeting

24h ago

PremiumCompany Announcements

Pharma Mar’s Zepzelca® Shows Promising Results in Lung Cancer Treatment

16d ago

PremiumCompany Announcements

Pharma Mar SA Reports on Recent Share Buy-Back Activities

24d ago

PremiumCompany Announcements

PharmaMar Seeks EMA Approval for New Lung Cancer Treatment

29d ago

PremiumCompany Announcements

Pharma Mar SA Updates on Share Buy-Back Program

1M ago

PremiumCompany Announcements

Pharma Mar Gains Approval for Cancer Drug in Argentina

1M ago

See All ES:PHM News

See All News >

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

― Insiders

2.41%

Mutual Funds

― Other Institutional Investors

93.68% Public Companies and

Individual Investors

Detailed Ownership Overview >

PHM FAQ

What was Pharma Mar SA’s price range in the past 12 months?

Pharma Mar SA lowest stock price was €31.82 and its highest was €105.80 in the past 12 months.

What is Pharma Mar SA’s market cap?

Pharma Mar SA’s market cap is $1.47B.

When is Pharma Mar SA’s upcoming earnings report date?

Pharma Mar SA’s upcoming earnings report date is Jul 24, 2025 which is in 35 days.

How were Pharma Mar SA’s earnings last quarter?

Pharma Mar SA released its earnings results on Apr 24, 2025. The company reported -€0.225 earnings per share for the quarter, missing the consensus estimate of -€0.11 by -€0.115.

Is Pharma Mar SA overvalued?

According to Wall Street analysts Pharma Mar SA’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Pharma Mar SA pay dividends?

Pharma Mar SA pays a Annually dividend of €0.8 which represents an annual dividend yield of 0.78%. See more information on Pharma Mar SA dividends here

What is Pharma Mar SA’s EPS estimate?

Pharma Mar SA’s EPS estimate is 0.03.

How many shares outstanding does Pharma Mar SA have?

Pharma Mar SA has 18,222,227 shares outstanding.

What happened to Pharma Mar SA’s price movement after its last earnings report?

Pharma Mar SA reported an EPS of -€0.225 in its last earnings report, missing expectations of -€0.11. Following the earnings report the stock price went up 0.371%.

Which hedge fund is a major shareholder of Pharma Mar SA?

Currently, no hedge funds are holding shares in ES:PHM

Pharma Mar SA Stock Smart Score

Outperform

Fundamentals

Return on Equity

10.15%

Trailing 12-Months

Asset Growth

-0.10%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Pharma Mar SA

Pharma Mar SA (PHM) is a biopharmaceutical company based in Spain, specializing in the research, development, and commercialization of innovative marine-derived drugs for oncology. The company is a leader in marine biotechnology, leveraging its expertise in marine biology to discover novel compounds with potential therapeutic applications. Pharma Mar's core products include Yondelis, a treatment for soft tissue sarcoma and ovarian cancer, and Aplidin, used for multiple myeloma. The company operates within the pharmaceutical sector, focusing on bringing groundbreaking cancer treatments to market.

PHM Earnings Call

Q4 2025

0:00 / 0:00

PHM Stock 12 Month Forecast

Average Price Target

€109.00

▲(34.57%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"26":"€26","47":"€47","68":"€68","89":"€89","110":"€110"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":109.9999998703474,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€110.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":109.0039600936,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€109.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":107.99999987270472,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€108.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[26,47,68,89,110],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2022","6":"Apr<br/>2023","9":"Oct<br/>2024","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,74.35,77.09230768233441,79.83461536466882,82.57692304700325,85.31923072933766,88.06153841167207,90.80384609400649,93.5461537763409,96.28846145867531,99.03076914100973,101.77307682334416,104.51538450567857,107.25769218801298,{"y":109.9999998703474,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,74.35,77.01568923796923,79.68137847593846,82.34706771390769,85.01275695187692,87.67844618984616,90.34413542781539,93.0098246657846,95.67551390375385,98.34120314172307,101.00689237969232,103.67258161766154,106.33827085563077,{"y":109.0039600936,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,74.35,76.93846152866959,79.52692305733919,82.11538458600877,84.70384611467837,87.29230764334797,89.88076917201757,92.46923070068715,95.05769222935675,97.64615375802634,100.23461528669594,102.82307681536554,105.41153834403514,{"y":107.99999987270472,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":98.224,"date":1601510400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":98.224,"date":1604188800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":98.224,"date":1604188800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":55.111,"date":1661990400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.669,"date":1664582400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.986,"date":1672531200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.845,"date":1680307200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.381,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.54,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.3,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.8,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.65,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.35,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >